公开(公告)号：US20230400205A1

公开(公告)日：2023-12-14

申请号：US18041444

申请日：2021-08-12

申请人： ASSOCIACAO BLC3 - CAMPUS DE TECNOLOGIA E INOVACAO ,  UNIVERSIDADE DE COIMBRA ,  UNIVERSIDADE DO MINHO ,  FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA

发明人： Joao Miguel DOS SANTOS ALMEIDA NUNES ,  Gabriela Conceicao DUARTE JORGE DA SILVA ,  Sandra Maria BRAGA FRANCO ,  Joao Manuel MACIEL LINHARES ,  Jose Miguel AZEVEDO PEREIRA ,  Quirina Alexandra PINTO DOS SANTOS COSTA ,  Elsa Maria RIBEIRO DOS SANTOS ANES ,  David Alexandre RODRIGUES PIRES

IPC分类号： F24F8/22 ,  F24F13/02 ,  F24F11/72 ,  F24F8/24 ,  F24F3/167 ,  F24F7/10

CPC分类号： F24F8/22 ,  F24F13/0236 ,  F24F11/72 ,  F24F8/24 ,  F24F3/167 ,  F24F7/10 ,  F24F2221/34

摘要： A system for improving indoor air quality for shared and confined spaces with people. This allows an improvement in surrounding air quality in indoor spaces and interaction situations with (i) groups of people among themselves (inter-person transmission), (ii) between people and the above-mentioned indoor spaces (confined spaces, buildings and/or airborne and/or overland and/or seaborne passenger transportation systems and/or confined patient transportation systems such as pods/incubators and others similar thereto), and also (iii) for interaction between people and invasive and non-invasive mechanical ventilation systems. The system proposes the use of a system based on fluid mechanics and UV wavelengths for inactivating viruses and bacteria.

公开(公告)号：US09732091B2

公开(公告)日：2017-08-15

申请号：US14901314

申请日：2014-06-26

申请人： UNIVERSIDADE DO PORTO ,  FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA

发明人： Lucilia Helena Ataide Saraiva ,  Maria Manuel Duque Vieira Marques Dos Santos ,  Nuno Alexandre Lousa Pereira ,  Clara Isabel Ferreira Pereira ,  Sara Gomes Moreira ,  Mariana Valencia Castanheira Ferreira Leao ,  Angelo Filipe Almeida Monteiro ,  Joana Oliveira Gama Soares

IPC分类号： C07D498/04 ,  A61K31/424 ,  A61K45/06

CPC分类号： C07D498/04 ,  A61K31/424 ,  A61K45/06 ,  A61K2300/00

摘要： The present application discloses novel family of Tryptophanol-Derived Oxazoloisoindolinones for use in the treatment of p53 associated conditions, such as cancer.These compounds are p53 activators and may be used in pharmaceutical compositions, alone or in combination with other chemotherapeutic agents.